Table 6. Return on investment analyses for desired TPP vaccine.
| Total development costs (US$) | Years needed for development | Minimum needed to achieve positive ROI |
|
|---|---|---|---|
| No. of people vaccinated in 1st year | coverage of target population in 1st year (%) | ||
|
$100 million |
15 |
180,000 |
3.0% |
| 20 |
210,000 |
3.5% |
|
| 30 |
270,000 |
4.5% |
|
|
$150 million |
15 |
240,000 |
4.0% |
| 20 |
300,000 |
5.0% |
|
| 30 |
420,000 |
7.0% |
|
|
$200 million |
15 |
330,000 |
5.5% |
| 20 |
420,000 |
7.0% |
|
| 30 |
540,000 |
9.0% |
|
| $400 million | 15 |
660,000 |
11.0% |
| 20 |
780,000 |
13.0% |
|
| 30 | 1,020,000 | 17.0% | |